Abstract:Key PointsAlthough for a long time necrosis was considered to be a purely accidental cell death subroutine, multiple lines of evidence now show that necrotic cell death can be regulated, both in its occurrence and in its course. The term 'necroptosis' was introduced by Yuan's research group in 2005 to indicate 'programmed' (as opposed to 'accidental') necrosis.The best characterized signal transduction cascade leading to necroptosis is initiated by ligand-bound tumour necrosis factor (TNF) receptor 1 (TNFR1), which allows for the assembly of a cytoplasmic supramolecular complex — TNFR complex I — that includes (among other proteins) TNFR-associated death domain (TRADD), cellular inhibitor of apoptosis 1 (cIAP1), cIAP2 and receptor-interacting protein kinase 1 (RIP1; also known as RIPK1).In complex I, RIP1 can be ubiquitylated by cIAPs and deubiquitylated by cylindromatosis (CYLD) and A20 (also known as TNFAIP3). Whereas ubiquitylated RIP1 promotes the activation of the nuclear factor κB (NF-κB) system, deubiquitylated RIP1 functions as a cell death-inducing kinase.On TNFR1 internalization, the so-called TNFR complex II is formed, which contains TRADD, FAS-associated protein with a death domain (FADD) and caspase 8. Normally, caspase 8 becomes activated in complex II, thereby igniting a pro-apoptotic caspase cascade. When caspase activation is prevented, however, RIP1 physically and functionally interacts with RIP3 (also known as RIPK3), thereby generating a necroptosis-inducing complex known as the necrosome.Necroptosis can also be ignited by pathogen recognition receptors, including Toll-like receptors, NOD-like receptors and retinoic acid-inducible gene I-like receptors, as well as in response to DNA damage, presumably by a poly(ADP-ribose) polymerase-1 (PARP1)-dependent signalling pathway.Although the underlying molecular mechanisms remain obscure, reactive oxygen species (ROS), bioenergetic metabolic cascades and the release of cytotoxic factors from lysosomes and mitochondria all contribute to the execution of necroptosis.Regulated necrosis has been seen in multiple, evolutionarily distant model organisms, including yeast, nematodes, fruit flies, rodents, primates and human cells, corroborating the notion that necroptosis may represent a phylogenetically conserved mechanism for programmed cell death.Numerous in vivo studies indicate that the inhibition of necroptosis (by genetic means or by RIP1-targeting agents called necrostatins) can confer consistent cytoprotection, suggesting that necroptosis may constitute a promising target for drug development.

Biological events and molecular signaling following MLKL activation during necroptosis

Necrosome core machinery: MLKL

Death at a funeral: Activation of the dead enzyme, MLKL, to kill cells by necroptosis

The molecular mechanisms of MLKL-dependent and MLKL-independent necrosis

The MLKL Channel in Necroptosis is an Octamer Formed by Tetramers in a Dyadic Process.

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Uncovering human mixed lineage kinase domain-like activation in necroptosis

Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization

Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis

The Many Faces of MLKL, the Executor of Necroptosis

The MLKL kinase-like domain dimerization is an indispensable step of mammalian MLKL activation in necroptosis signaling

Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis

Oligomerization-driven MLKL ubiquitylation antagonizes necroptosis

Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death

Acylation of MLKL Impacts Its Function in Necroptosis

Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.

Surviving death: emerging concepts of RIPK3 and MLKL ubiquitination in the regulation of necroptosis

Direct Activation of Human MLKL by a Select Repertoire of Inositol Phosphate Metabolites

Molecular mechanisms of necroptosis: an ordered cellular explosion

Mixed Lineage Kinase Domain-Like Protein MLKL Causes Necrotic Membrane Disruption Upon Phosphorylation by RIP3.

Structural Insights into RIP3-Mediated Necroptotic Signaling